From 13 till 17 September 2024: HIGHLIGHTS FROM ESMO
Your direct line with Barcelona
The European Society of Medical Oncology (ESMO) 2024 brings together leading experts in the different fields of cancer from around the world. And this year they gather together in Barcelona, Spain. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.
Stay tuned, and get ready for an exciting and informative journey!
Latest Presidential highlights
Arguably one of the most anticipated presentations at ESMO 2024 featured the overall survival (OS) data of the pivotal phase III KEYNOTE-522 trial. Based on a convincing benefit in event-free
Latest Daily highlights
Dr Jérémy Blanc, medical oncologist in training at the Jules Bordet institute in Brussels discusses the key results of four clinical trials that were presented during the second proffered paper
In this video, Prof Dr Johan Vansteenkiste, a thoracic oncologist at the University Hospitals Leuven, discusses a selection of abstracts presented during the proffered paper session on non-metastatic lung cancer
Prof Dr Christine Gennigens, a medical oncologist at the University Hospital of CHU de Liège, focused on two studies presented during the mini oral session 2 on gynaecological cancers.
In this video, Dr Françoise Derouane, a medical oncologist at the University Hospitals Leuven, discusses a selection of abstracts presented during the proffered paper session on metastatic breast cancer during
In this video, Dr Francesco Sclafani, digestive oncologist at the Institut Jules Bordet,
summarises the key results of four clinical trials that were presented during the second proffered paper session
While ESMO did not feature any practice-changing presentations in the field of melanoma, it did provide interesting, long-term updates of pivotal clinical trials in addition to important insights from real-world
For his discussion of the mini-oral session on head and neck cancer at ESMO 2024, Dr Michael Saerens, medical oncologist at the University Hospital Ghent selected five interesting presentations.
The proffered paper session on metastatic non-small cell lung cancer (NSCLC) at ESMO 2024 focussed on three main topics: immune checkpoint inhibitor (ICI) combinations, the management of EGFR-mutant NSCLC after
In this video, Prof Dr Jeroen Dekervel, digestive oncologist at the University Hospitals Leuven discusses two clinical trials that were presented during a first proffered paper session on upper digestive
In this video, Dr Annelies Verbiest, medical oncologist at the University hospital Antwerp shares the results of 5 clinical trials that were presented in a first of two proffered paper
In this video, Dr Eline Naert, medical oncologist at the University hospital Ghent discusses a selection of abstracts that were presented during the mini oral session on early-stage breast cancer
Made possible with the financial support of our partners.
All videos are developed independently and are non-promotional.
